Aortica said today that the FDA approved the use of Medtronic‘s (NYSE:MDT) Valiant Navion stent graft system alongside Aortica’s AortaFit in a physician sponsored IDE study. The study, being run by principal investigator Dr. Benjamin Starnes at the University of Washington, will now use the Valiant Navion as a platform for fenestrated endovascular repair together with […]
Aortica raises $1m, looks for $4m more
Aortica has raised $1 million in a new round of mixed financing, according to an SEC filing posted this week. Money in the round comes from 11 unnamed investors, with the 1st sale recorded on June 13 this year. The company is looking for an additional $3 million in the round before closing it, according […]
OmniGuide vet Avila gets picked as new IlluminOss CEO | Personnel Moves
IlluminOss Medical said today it picked ex-OmniGuide sales & marketing veep Manny Avila as its new chief exec. Prior to his time as sales & marketing veep with OmniGuide, Avila served as veep of commercial operations and surgical solutions in Europe for Covidien, and had management roles at Aspect Medical, Synthes Inc. and Haemonetics (NYSE:HAE), IlluminOss […]
AAA IDE study expands, hopes to add Aortica software
Aortica said today that a physician-sponsored investigational device exemption study of abdominal aortic aneurysm-treating endografts gained FDA approval to introduce a new software-planning tool and expand the number of endografts in the study. The trial is designed to assess new technology that could reduce the need for invasive surgeries in patients with aneurysms that are “too […]
Startup Aortica raises $7m in Series A round, names Douthitt CEO
Aortica said it raised $7 million in a Series A round for development of its treatment for abdominal aortic aneurysms and named a medtech veteran as its new CEO.
Aortica said medtech veteran Tom Douthitt will helm the corner office, with co-founder Dr. Ben Starnes serving as chief medical officer.
